The Differences Levels of RANTES and PF4 Based on the Storage of Platelet Concentrate
DOI:
https://doi.org/10.24293/ijcpml.v27i3.1577Keywords:
Regulated upon activation, normal T-cell expressed and presumably secreted, platelet factor 4, platelet concentrateAbstract
Blood component transfusion is often used as the primary therapy as it is still considered safe. Platelet Concentrate (PC) transfusion plays a critical role in preventing bleeding in patients with severe thrombocytopenia. Allergic reactions are the most frequent transfusion reactions after PC administration. Regulated on Activation Normal T-Cell Expressed and Secreted (RANTES) and Platelet Factor 4 (PF4) cytokines released by platelets during PC storage are responsible for allergic reactions after transfusion. The purpose of this study was to analyze changes in RANTES and PF4 levels during PC storage. This study was an observational analytical research with a time series design carried out at the Clinical Pathology Laboratory and Blood Bank of the Dr. Soetomo Hospital, Surabaya, from June to July 2019. RANTES and PF4 levels in 27 bags derived from Platelet Rich Plasma (PRP) on storage for day 1, day 3, and day five were measured using the ELISA sandwich method. Subject same variant test or Friedman test was used for statistical analysis. The results showed no significant differences in RANTES and PF4 levels based on the storage duration of PCs on days 1, 3, and 5, with p=0.717, and p=0.614, respectively. There was no difference in the storage of PCs from day 1 to day five, and there was no effect on allergic reactions after PC transfusion.
Downloads
References
Kemenkes RI. Peraturan Menteri Kesehatan Republik Indonesia nomor 91 tahun 2015 tentang standar pelayanan tranfusi darah. 2016; 6-7.
Forest SK, Hod EA. Management of the platelet refractory patient. Hematology/Oncology Clinics of
North America, 2016; 30(3): 665-77.
Sut C, Tariket S, Aubron C. The non-hemostatic aspect of transfused platelets. Frontiers in Medicine, 2018; 5: 1-11.
Ahmed A, Leheta O, Younes S. In-vitro assessment of platelet storage lesion in leukoreduced random
donor platelet concentrate. Blood Transfusion, 2010; 8(1): 28-35.
Armenia D, Tambunan BA. Evaluation of storage length to blood component platelet concentrate
quality in the Blood Bank, Dr. Soetomo General Hospital Surabaya Indonesia. Indian Journal of
Forensic Medicine & Toxicology, 2020; 14(4): 908-913.
Seghatchian J. Platelet storage lesion: An update on the impact of various leukoreduction processes on the biological response modifiers. Transfusion and Apheresis Science, 2006; 34(1): 125-30.
Elabscience. Manual book-human RANTES (Regulated on Activation, Normal T-Cell Expressed and Secreted) ELISA kit. 2017; 1-11.
Elabscience. Manual book-human PF4 (Platelet Factor 4) ELISA kit. 2017; 1-11.
Shrivastava M. The platelet storage lesion. Transfusion and Apheresis Science, 2009; 41(2): 105-13.
Wadhwa M, Seghatchian MJ, Dilger P, Sands D, Krailadisiri P, et al. Cytokines in WBC-reduced
apheresis PCs during storage: A comparison of two WBC-reduction methods. Transfusion, 2000; 40(9):
-26.
Shukla R, Patel T, Gupte S. Release of cytokines in stored whole blood and red cell concentrate: Effect of leukoreduction. Asian Journal of Transfusion Science, 2015; 9(2): 145-149.
Tormey C, Stack G. Use of a cytokine-release assay to demonstrate loss of platelet secretory capacity during blood bank processing and storage. Archives of Pathology & Laboratory Medicine, 2014; 138(11):
-7.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.